title: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
authors.forename: Jeremiah
authors.initials: J
authors.lastname: Joson
authors.forename: Casey
authors.initials: C
authors.lastname: Grover
authors.forename: Caitlin
authors.initials: C
authors.lastname: Downer
authors.forename: Thejeswi
authors.initials: T
authors.lastname: Pujar
authors.forename: Arash
authors.initials: A
authors.lastname: Heidari
mesh_terms: D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use*; D000617:Aminoglycosides / Q000009:adverse effects / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017576:Daptomycin / Q000627:therapeutic use*; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D000069349:Linezolid; D000077427:Lipoglycopeptides; D008279:Magnetic Resonance Imaging; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus; D008826:Microbial Sensitivity Tests; D008943:Mitral Valve; D023303:Oxazolidinones / Q000009:adverse effects / Q000627:therapeutic use*; D020335:Paraparesis / Q000209:etiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D017211:Treatment Failure
chemical_list: D000081:Acetamides; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000077427:Lipoglycopeptides; D023303:Oxazolidinones; D000069349:Linezolid; D017576:Daptomycin; C487637:telavancin